Cancer Home > Temsirolimus
Clinical EffectsTemsirolimus has been shown to extend survival time in people with advanced kidney cancer who were not previously treated for their cancer. In this study, people given temsirolimus survived an average of 3.6 months longer than people given a different kidney cancer treatment (interferon-alpha or INF-alpha).
When and How to Receive This MedicineSome general considerations to keep in mind during treatment with temsirolimus include the following:
- This medication is given as an injection into a vein (an intravenous, or IV, injection) once a week.
- A healthcare provider will administer the injection in a healthcare setting, such as a hospital or clinic.
- The injections are given slowly, over a period of 30 to 60 minutes. This is called an intravenous infusion.
- You will receive a different IV medication about 30 minutes before your temsirolimus dose to help prevent allergic reactions to temsirolimus.
- For the medication to work properly, it must be used as prescribed. Make sure to keep all of your appointments to receive this medication.